RIPK1 and ulcerative colitis: To expand our tissue target engagement analysis beyond skin samples, we evaluated RIPK1 target engagement in colon and synovial tissues, as these tissues are the major sites of inflammation in TNF‐dependent diseases such as ulcerative colitis and rheumatoid arthritis, respectively.